- Business Wire•9 days ago
Shionogi presents New Data on Cefiderocol (S-649266), a Siderophore Cephalosporin, and S-033188 a Cap-Dependent Endonuclease Inhibitor for Treatment of Influenza at ECCMID 2017
OSAKA, Japan--(BUSINESSWIRE)-- Shionogi & Co., Ltd. today announced it will be presenting new data on cefiderocol (S-649266), an investigational siderophore cephalosporin in late stage development with ...
We're sorry this is all we were able to find about this topic.
SH0.BE: Summary for SHIONOGI + CO. LTD - Yahoo Finance
SHIONOGI + CO. LTD (SH0.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
As of 8:16AM CEST. Market open.
|Day's range||46.47 - 46.47|
|52-week range||44.71 - 49.67|
|PE ratio (TTM)||N/A|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|